Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06295783 · ClinicalTrials.gov registry record
Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect
A clinical trial of Radiation, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06295783: Recruiting study of Radiation, sponsored by M.D. Anderson Cancer Center.
NCT06295783 is a study of Radiation that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06295783, a study of Radiation, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn more about how you would rate the intensity or severity of your symptoms during or after radiation therapy using questionnaires with different rating scales.
Primary Outcome
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)
Conditions Studied
Interventions
- OTHER MDASI-HN
- OTHER EORTC QLQ-C30
- OTHER EORTC HN35
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-06-10 |
| Est. Completion | 2027-02-01 |
What NCT06295783 shows while recruiting
NCT06295783 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Radiation appearing as the primary indexed condition, and to 3 interventions - of which MDASI-HN is the first listed.
NCT06295783 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06295783 about?
NCT06295783 is a clinical study titled "Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect". To learn more about how you would rate the intensity or severity of your symptoms during or after radiation therapy using questionnaires with different rating scales.
What is the current status of trial NCT06295783?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2024-06-10. Estimated completion is 2027-02-01.
What conditions does trial NCT06295783 study?
This clinical trial studies the following conditions: Radiation.
What interventions are being tested in trial NCT06295783?
The interventions under investigation include: MDASI-HN (OTHER), EORTC QLQ-C30 (OTHER), EORTC HN35 (OTHER).
Who is sponsoring clinical trial NCT06295783?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06295783 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI